This post has been de-listed
It is no longer included in search results and normal feeds (front page, hot posts, subreddit posts, etc). It remains visible only via the author's post history.
This is a good time to average down, I have averaged down from 6.5 dollars to 2.72 dollars, the goal is to average down to 2 dollars, hopefully I can reach this goal before the stock price start flying toward the sky.
Might not be much time left. With dosage results from Evangeline coming in a couple weeks, we could see $2 by August.
Yes, Endoxifen has been achieving positive results in trials for the last decade. Most recent was an Australian trial that Atossa halted early due to tremendous success.
Goes the other way? A risk I suppose. I’ve got 150k bet that it doesn’t.
Subreddit
Post Details
- Posted
- 1 year ago
- Reddit URL
- View post on reddit.com
- External URL
- reddit.com/r/AtossaThera...
$2 by August if the Pk results include some sort of indication the patients improved with Endox and want to keep taking it.
Certainly not all we will go, this is just the prelims. I’m still hoping for a $40/pps buyout once interim results come in from Eva, Ispy, and final results from Karisma.